Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition

[1]  B. Skogseid,et al.  Clinical testing for mutations in the MEN1 gene in Sweden: a report on 200 unrelated cases. , 2007, The Journal of clinical endocrinology and metabolism.

[2]  T. Ørntoft,et al.  No evidence of somatic aryl hydrocarbon receptor interacting protein mutations in sporadic endocrine neoplasia. , 2007, Endocrine-related cancer.

[3]  Louise Izatt,et al.  Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia. , 2007, The Journal of clinical endocrinology and metabolism.

[4]  F. Collins,et al.  The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations. , 2007, The Journal of clinical endocrinology and metabolism.

[5]  L. Aaltonen,et al.  Mutation analysis of aryl hydrocarbon receptor interacting protein (AIP) gene in colorectal, breast, and prostate cancers , 2007, British Journal of Cancer.

[6]  T. Ørntoft,et al.  Raitila, A. et al. No evidence of somatic aryl hydrocarbon receptor interacting protein mutations in sporadic endocrine neoplasia. Endocr. Relat. Cancer 14, 901-906 , 2007 .

[7]  H. Höfler,et al.  Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans , 2006, Proceedings of the National Academy of Sciences.

[8]  R. Paschke,et al.  Pituitary Adenoma Predisposition Caused by Germline Mutations in the AIP Gene , 2006, Science.

[9]  C. Marcocci,et al.  Genetic analyses in familial isolated hyperparathyroidism: implication for clinical assessment and surgical management , 2006, Clinical endocrinology.

[10]  B. Teh,et al.  Familial isolated hyperparathyroidism is linked to a 1.7 Mb region on chromosome 2p13.3–14 , 2005, Journal of Medical Genetics.

[11]  S. Ellard,et al.  Detection of an MEN1 gene mutation depends on clinical features and supports current referral criteria for diagnostic molecular genetic testing , 2005, Clinical endocrinology.

[12]  T. Dwight,et al.  A report of a national mutation testing service for the MEN1 gene: clinical presentations and implications for mutation testing , 2005, Journal of Medical Genetics.

[13]  C. Marcocci,et al.  Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors. , 2004, The Journal of clinical endocrinology and metabolism.

[14]  T. Ebeling,et al.  Effect of multiple endocrine neoplasia type 1 (MEN1) gene mutations on premature mortality in familial MEN1 syndrome with founder mutations. , 2004, The Journal of clinical endocrinology and metabolism.

[15]  B. Teh,et al.  Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications , 2004, Journal of Medical Genetics.

[16]  J. Carpten,et al.  Germline and de novo mutations in the HRPT2 tumour suppressor gene in familial isolated hyperparathyroidism (FIHP) , 2004, Journal of Medical Genetics.

[17]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[18]  J. Carpten,et al.  Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome. , 2004, The Journal of clinical endocrinology and metabolism.

[19]  M. Rothmund,et al.  Prevalence of multiple endocrine neoplasia type 1 in young patients with apparently sporadic primary hyperparathyroidism or pancreaticoduodenal endocrine tumours , 2003, The British journal of surgery.

[20]  J. Carpten,et al.  Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. , 2003, The New England journal of medicine.

[21]  K Hammje,et al.  HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours , 2003, Journal of medical genetics.

[22]  J. Carpten,et al.  HRPT2, encoding parafibromin, is mutated in hyperparathyroidism–jaw tumor syndrome , 2002, Nature Genetics.

[23]  J. Rastad,et al.  Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. , 2002, The Journal of clinical endocrinology and metabolism.

[24]  T. Dwight,et al.  Involvement of the MEN1 gene locus in familial isolated hyperparathyroidism. , 2002, European journal of endocrinology.

[25]  W. Simonds,et al.  Familial Isolated Hyperparathyroidism: Clinical and Genetic Characteristics of 36 Kindreds , 2002, Medicine.

[26]  John P. Bilezikian,et al.  CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2 , 2001 .

[27]  C. Larsson,et al.  Founder effect in multiple endocrine neoplasia type 1 (MEN 1) in Finland , 2001, Journal of medical genetics.

[28]  Hiroto Yamashita,et al.  Screening of the Men1 gene and discovery of germ-line and somatic mutations in apparently sporadic parathyroid tumors. , 2000, Cancer research.

[29]  Roijers,et al.  Criteria for mutation analysis in MEN 1‐suspected patients: MEN 1 case‐finding , 2000, European journal of clinical investigation.

[30]  J. Rastad,et al.  Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor. , 2000, The Journal of clinical endocrinology and metabolism.

[31]  H. Röher,et al.  Lack of MEN1 gene mutations in 27 sporadic insulinomas , 2000, European journal of clinical investigation.

[32]  C. Larsson,et al.  Familial isolated hyperparathyroidism as a variant of multiple endocrine neoplasia type 1 in a large Danish pedigree. , 2000, The Journal of clinical endocrinology and metabolism.

[33]  A. Dackiw,et al.  Screening for MEN1 mutations in patients with atypical endocrine neoplasia. , 1999, Surgery.

[34]  C. Larsson,et al.  A family with isolated hyperparathyroidism segregating a missense MEN1 mutation and showing loss of the wild-type alleles in the parathyroid tumors. , 1998, American journal of human genetics.

[35]  J. Rastad,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Parathyroid MEN1 Gene Mutations in Relation to Clinical Characteristics of Nonfamilial Primary Hyperparathyroidism* , 2022 .

[36]  C. Larsson,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Alterations of the MEN1 Gene in Sporadic , 2022 .

[37]  Öberg,et al.  The ultimate biochemical diagnosis of endocrine pancreatic tumours in MEN‐1 , 1998, Journal of internal medicine.

[38]  F. Collins,et al.  Somatic mutation of the MEN1 gene in parathyroid tumours , 1997, Nature Genetics.

[39]  Y Wang,et al.  Positional cloning of the gene for multiple endocrine neoplasia-type 1. , 1997, Science.

[40]  E. Brown,et al.  Markedly reduced activity of mutant calcium-sensing receptor with an inserted Alu element from a kindred with familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. , 1997, The Journal of clinical investigation.

[41]  C. Larsson,et al.  Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas. , 1996, The Journal of clinical endocrinology and metabolism.

[42]  J. Seidman,et al.  Mutations in the human Ca2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism , 1993, Cell.

[43]  B. Ponder,et al.  Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A , 1993, Nature.